Details Basic Details Status Ongoing Last Updated Friday, March 8, 2024 Original Posting Date Friday, July 10, 2020 Health Outcome(s) adverse central nervous system reactions, tardive dyskinesia Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR Yes Result(s) (2) Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Descriptive Analysis Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: An Updated Descriptive Analysis Regulatory Link(s) (1) FDA Approval Package Materials